Innovation Focused

Aura Biosciences is an innovation-driven company focused on the development of drugs using tumor targeted Pseudovirions, breakthrough technology discovered and patented by Dr. John Schiller at the National Cancer Institute (NCI).

Pseudovirions are a novel approach that harness the power of synthetic biology and viral evolution. Aura has developed methods to manufacture these synthetic viral structures and combine them with multiple types of drugs creating a new generation of highly efficient targeted molecules.